Risk-Adapted Chemo Strategy Proves Effective in Adult Burkitt Lymphoma

(MedPage Today) -- Study Authors: Mark Roschewski, Kieron Dunleavy, et al.Target Audience and Goal Statement: Oncologists, hematologistsThe goal of this study was to determine if dose-adjusted etoposide, doxorubicin, cyclophosphamide, vincristine...